On CNBC's "Mad Money Lightning Round," Jim Cramer said AbbVie Inc. (NYSE:ABBV) is doing "very, very well." However, he added that Abbott Laboratories (NYSE:ABT) remains his favorite in the group right ...

因为，如果说拜登自己是1.0版本，那表现乏善可陈的哈哈姐，只能称得上是拜登的0.8版本，又或者0.5版本了。因此，选择哈哈姐，对于美国选民来说，只会延续现有的政策路线。而这种延续性对于选民来说，根本不算好消息。